Back to Trades
Grant4
Acumen Pharmaceuticals, Inc.
ABOS
Total Value
$239.8K
Company Information
- Company Name
- Acumen Pharmaceuticals, Inc.
- Ticker Symbol
- ABOS
- CIK
- 0001576885
Insider Information
- Name
- Schacterle Amy
- Role
- Chief Regulatory Officer
- Location
- NEWTON, MA
Officer
Filing Details
- Filing Date
- Jan 21, 2026
- Transaction Date
- Jan 16, 2026
- Accession Number
- 0001628280-26-002957
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 16, 2026 | Common Stock | 84,600 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 16, 2026 | Derivative | 126,900 | $1.89 | Grant/Award | $239.8K |
Footnotes
- (F1)Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date.
- (F2)The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.